KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to 0.1.

  • Aquestive Therapeutics' Asset Utilization Ratio fell 11975.8% to 0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1, marking a year-over-year decrease of 11975.8%. This contributed to the annual value of 0.01 for FY2024, which is 9856.37% down from last year.
  • According to the latest figures from Q3 2025, Aquestive Therapeutics' Asset Utilization Ratio is 0.1, which was down 11975.8% from 0.13 recorded in Q2 2025.
  • Aquestive Therapeutics' 5-year Asset Utilization Ratio high stood at 0.87 for Q4 2023, and its period low was 0.13 during Q2 2025.
  • Its 5-year average for Asset Utilization Ratio is 0.48, with a median of 0.54 in 2021.
  • Per our database at Business Quant, Aquestive Therapeutics' Asset Utilization Ratio soared by 13158.09% in 2022 and then tumbled by 12684.47% in 2025.
  • Quarter analysis of 5 years shows Aquestive Therapeutics' Asset Utilization Ratio stood at 0.54 in 2021, then soared by 44.24% to 0.78 in 2022, then rose by 11.14% to 0.87 in 2023, then tumbled by 98.9% to 0.01 in 2024, then plummeted by 1172.42% to 0.1 in 2025.
  • Its last three reported values are 0.1 in Q3 2025, 0.13 for Q2 2025, and 0.02 during Q1 2025.